Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Imatinib Mesylate since 2013?

What pharmacies pay, not what you pay. Imatinib Mesylate has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Imatinib Mesylate 400 MG Tab: $182 per unit at the 2016 survey and $2.68 at 2026 (−99%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Imatinib Mesylate2 products in NADAC
2products with a price history
  1. Imatinib Mesylate has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 2 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Imatinib Mesylate 400 MG Tab

Generic

$182 per unit at the 2016 year-end survey (5 NDCs) and $2.68 at the 2026 survey (15 NDCs): −99%.

$0$1822016: median $182 per unit, 5 NDCs priced2017: median $124 per unit, 8 NDCs priced2018: median $20.40 per unit, 13 NDCs priced2019: median $9.33 per unit, 18 NDCs priced2020: median $5.92 per unit, 18 NDCs priced2021: median $3.67 per unit, 20 NDCs priced2022: median $2.46 per unit, 21 NDCs priced2023: median $1.78 per unit, 19 NDCs priced2024: median $2.56 per unit, 17 NDCs priced2025: median $3.09 per unit, 15 NDCs priced2026: median $2.68 per unit, 15 NDCs priced201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2016 (2016-12-28)$1825
2017 (2017-12-27)$1248
2018 (2018-12-26)$20.4013
2019 (2019-12-25)$9.3318
2020 (2020-12-30)$5.9218
2021 (2021-12-29)$3.6720
2022 (2022-12-28)$2.4621
2023 (2023-12-27)$1.7819
2024 (2024-12-25)$2.5617
2025 (2025-12-31)$3.0915
2026 (2026-11-11)$2.6815

Imatinib Mesylate 100 MG Tab

Generic

$68.17 per unit at the 2016 year-end survey (5 NDCs) and $0.644 at the 2026 survey (17 NDCs): −99%.

$0$68.172016: median $68.17 per unit, 5 NDCs priced2017: median $46.79 per unit, 8 NDCs priced2018: median $6.09 per unit, 13 NDCs priced2019: median $4.95 per unit, 18 NDCs priced2020: median $3.14 per unit, 18 NDCs priced2022: median $0.812 per unit, 21 NDCs priced2023: median $0.609 per unit, 21 NDCs priced2024: median $0.668 per unit, 17 NDCs priced2025: median $0.874 per unit, 19 NDCs priced2026: median $0.644 per unit, 17 NDCs priced201620182020202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2016 (2016-12-28)$68.175
2017 (2017-12-27)$46.798
2018 (2018-12-26)$6.0913
2019 (2019-12-25)$4.9518
2020 (2020-12-30)$3.1418
2022 (2022-12-28)$0.81221
2023 (2023-12-27)$0.60921
2024 (2024-12-25)$0.66817
2025 (2025-12-31)$0.87419
2026 (2026-11-11)$0.64417

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Imatinib Mesylate?

The FDA Orange Book lists 12 generic makers as marketed in its largest dosage form for Imatinib Mesylate, and the first generic approval is dated 3 December 2015. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Imatinib Mesylate on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).